CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
27 hedge funds and large institutions have $12M invested in Cymabay Therapeutics in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Holders
27
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$583K | |
| 2 | +$546K | |
| 3 | +$26.8K | |
| 4 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
+$13.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$7.18K |
Top Sellers
| 1 | -$154K | |
| 2 | -$88.8K | |
| 3 | -$33K | |
| 4 |
Goldman Sachs
New York
|
-$32K |
| 5 |
KCM
Kingdon Capital Management
New York
|
-$30.8K |